Back to search
FDAFDA · Food and drugs·Recall number Z-2994-2018

Diagnostica Stago STA N®oplastine® CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. REF: 00666 The STA® - N®oplastine® CI kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R®, STA Compact® and STA Satellite®. (In the USA this procedure has been assigned to the moderate complexity category per CLIA 1988 - CDC Analyte Code 4922; CDC Test System Codes 4677 and 4875).

Published September 19, 2018 · Recall initiated: July 24, 2018

Summary

FDA records medical device Class II recall Z-2994-2018, published September 19, 2018 and initiated July 24, 2018. Recalling firm: Diagnostica Stago, Inc.; Status: Terminated; Reported quantity: 5 kits; Lot: Lot Number/Exp. Date/UDI 251426 2018-11-30 (01)03607450006667(11)161130(17)181130(10)251426(241)00666; 251763 2019-02-28 (01)03607450006667(11)170228(17)190228(10)251763(241)00666. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Diagnostica Stago, Inc.
Distributor
Nationwide
Lot
Lot Number/Exp. Date/UDI 251426 2018-11-30 (01)03607450006667(11)161130(17)181130(10)251426(241)00666; 251763 2019-02-28 (01)03607450006667(11)170228(17)190228(10)251763(241)00666
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Diagnostica Stago STA N®oplastine® CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. REF: 00666 The STA® - N®oplastine® CI kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R®, STA Compact® and STA Satellite®. (In the USA this procedure has been assigned to the moderate complexity category per CLIA 1988 - CDC Analyte Code 4922; CDC Test System Codes 4677 and 4875). recalled?

Yes. FDA published recall Z-2994-2018 on September 19, 2018. Reported hazard: QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)

What should I do if I have this product?

Voluntary: Firm initiated · Letter